Risk of Fracture with Thiazolidinediones: Disease or Drugs?

Marloes T. Bazelier, Peter Vestergaard, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Frank de Vries

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)450-457
JournalCalcified Tissue International
Volume90
Issue number6
DOIs
Publication statusPublished - Jun 2012

Keywords

  • Thiazolidinedione
  • Type 2 diabetes mellitus
  • Fracture risk
  • Osteoporosis

Cite this

Bazelier, M. T., Vestergaard, P., Gallagher, A. M., van Staa, T-P., Cooper, C., Leufkens, H. G. M., & de Vries, F. (2012). Risk of Fracture with Thiazolidinediones: Disease or Drugs? Calcified Tissue International, 90(6), 450-457. https://doi.org/10.1007/s00223-012-9591-8